← Open Payments lookup

MICHAEL FRAZIER: Open Payments

NPI 1225396591 · WESTMINSTER, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$5,506 in 267 payments from 20 companies in 2025. Trend: 2023 $17 · 2024 $1,875 · 2025 $5,506

Food & beverage: $5,506
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)48$800
Neurocrine BioSciences, Inc.27$677
Teva Pharmaceuticals USA, Inc.37$609
E.R. Squibb & Sons, L.L.C.17$554
Alkermes, Inc.25$531
ABBVIE INC.30$517
Vanda Pharmaceuticals Inc.14$333
Lundbeck LLC15$323
Janssen Pharmaceuticals, Inc12$285
Axsome Therapeutics, Inc.10$195

Products named: CAPLYTA, INGREZZA, COBENFY, ARISTADA, VRAYLAR, REXULTI, FANAPT, AUSTEDO XR.

Industry payments across CA — which companies pay providers there.